blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2788024

EP2788024 - ANTIBODY FORMULATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.10.2016
Database last updated on 14.05.2024
Most recent event   Tooltip07.10.2016Application deemed to be withdrawnpublished on 09.11.2016  [2016/45]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2014/42]For all designated states
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / FAST, Jonas
Aeussere Baselstrasse 93
4125 Riehen / CH
02 / FISCHER, Stefan
Bachlettenstrasse 29
4054 Basel / CH
03 / MUELLER, Robert
Wettsteinallee 63
4058 Basel / CH
 [2014/42]
Representative(s)Brodbeck, Michel
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2014/42]
Application number, filing date12795799.103.12.2012
WO2012EP74182
Priority number, dateEP2011019224306.12.2011         Original published format: EP 11192243
[2014/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013083497
Date:13.06.2013
Language:EN
[2013/24]
Type: A1 Application with search report 
No.:EP2788024
Date:15.10.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 13.06.2013 takes the place of the publication of the European patent application.
[2014/42]
Search report(s)International search report - published on:EP13.06.2013
ClassificationIPC:A61K39/395, C07K16/28
[2014/42]
CPC:
C07K16/2884 (EP,US); A61K39/39591 (EP,US); A61K9/19 (EP,US);
A61P35/00 (EP); A61P35/02 (EP); A61P37/00 (EP);
C07K2317/24 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/42]
TitleGerman:ANTIKÖRPER-FORMULIERUNG[2014/42]
English:ANTIBODY FORMULATION[2014/42]
French:FORMULATION D'ANTICORPS[2014/42]
Entry into regional phase07.07.2014National basic fee paid 
07.07.2014Designation fee(s) paid 
07.07.2014Examination fee paid 
Examination procedure15.05.2014Amendment by applicant (claims and/or description)
07.07.2014Examination requested  [2014/42]
22.01.2016Despatch of a communication from the examining division (Time limit: M04)
02.06.2016Application deemed to be withdrawn, date of legal effect  [2016/45]
27.06.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/45]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.01.2016
Fees paidRenewal fee
05.12.2014Renewal fee patent year 03
04.01.2016Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]WO2008079246  (MEDAREX INC [US], et al) [X] 1-7,9-13,15,19,20,33,35 * example 13; claim 18 * [Y] 34 [I] 8,14,16-18,21-23,29-32;
 [Y]WO2011095498  (HOFFMANN LA ROCHE [CH], et al) [Y] 34 * abstract *;
 [ID]WO2008144890  (ARIUS RES INC [CA]) [ID] 24-28 * figure 22 *;
 [A]  - WANG W ET AL, "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, (20070101), vol. 96, no. 1, doi:10.1002/JPS.20727, ISSN 0022-3549, pages 1 - 26, XP009084505 [A] 1-35 * the whole document *

DOI:   http://dx.doi.org/10.1002/jps.20727
 [A]  - NICHOLAS W WARNE, "Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 78, no. 2, doi:10.1016/J.EJPB.2011.03.004, ISSN 0939-6411, (20110303), pages 208 - 212, (20110313), XP028203394 [A] 1-35 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.ejpb.2011.03.004
by applicantWO02094879
 US2003103985
 WO2008144890
 WO9316185
 US5571894
 US5587458
 US5869046
 EP0404097
 WO9301161
 US6248516
 US4816567
 US5821337
 US7527791
 US6982321
 US7087409
 US6075181
 US6150584
 US5770429
 US7041870
 US2007061900
 US7189826
 US5750373
 US2005079574
 US2005119455
 US2005266000
 US2007117126
 US2007160598
 US2007237764
 US2007292936
 US2009002360
 WO9308829
 US5731168
 WO2009089004
 US4676980
 US2006025576
 US2008069820
 WO2008077546
 US2003157108
 US2004093621
 WO0061739
 WO0129246
 US2003115614
 US2002164328
 US2004132140
 US2004110704
 US2004110282
 US2004109865
 WO03085119
 WO03084570
 WO2005035586
 WO2005035778
 WO2005053742
 WO0231140
 WO2004056312
 WO03085107
 WO03011878
 US6602684
 US2005123546
 WO9730087
 WO9858964
 WO9922764
 US5500362
 WO2006029879
 WO2005100402
 US6737056
 US7332581
 US6194551
 WO9951642
 US2005014934
 US7371826
 US5648260
 US5624821
 WO9429351
 US7521541
 US5648237
 US5789199
 US5840523
 US5959177
 US6040498
 US6420548
 US7125978
 US6417429
    - KABAT ET AL., Sequences of Proteins of Immunological Interest, NIH PUBLICATION 91-3242, (1991), vol. 1-3
    - CHOTHIA; LESK, J. MOL. BIOL., (1987), vol. 196, pages 901 - 917
    - ALMAGRO; FRANSSON, FRONT. BIOSCI., (2008), vol. 13, pages 1619 - 1633
    - FLATMAN ET AL., J. CHROMATOGR. B, (2007), vol. 848, pages 79 - 87
    - KINDT ET AL., Kuby Immunology, W.H. FREEMAN AND CO., (2007), page 91
    - PORTOLANO ET AL., J. IMMUNOL., (1993), vol. 150, pages 880 - 887
    - CLARKSON ET AL., NATURE, (1991), vol. 352, pages 624 - 628
    - CHEN ET AL., J. MOL. BIOL., (1999), vol. 293, pages 865 - 881
    - PRESTA ET AL., CANCER RES., (1997), vol. 57, pages 4593 - 4599
    - HUDSON ET AL., NAT. MED., (2003), vol. 9, pages 129 - 134
    - PLUCKTHIIN, The Pharmacology of Monoclonal Antibodies, SPRINGER-VERLAG, (1994), vol. 113, pages 269 - 315
    - HOLLINGER ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 6444 - 6448
    - MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 6851 - 6855
    - RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 329
    - QUEEN ET AL., PROC. NAT'L ACAD. SCI. USA, (1989), vol. 86, pages 10029 - 10033
    - KASHMIRI ET AL., METHODS, (2005), vol. 36, pages 25 - 34
    - PADLAN, MOL. IMMUNOL., (1991), vol. 28, pages 489 - 498
    - DALL'ACQUA ET AL., METHODS, (2005), vol. 36, pages 43 - 60
    - OSBOURN ET AL., METHODS, (2005), vol. 36, pages 61 - 68
    - KLIMKA ET AL., BR. J. CANCER, (2000), vol. 83, pages 252 - 260
    - SIMS ET AL., J. IMMUNOL., (1993), vol. 151, page 2296
    - CARTER ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, page 4285
    - PRESTA ET AL., J. IMMUNOL., (1993), vol. 151, page 2623
    - BACA ET AL., J. BIOL. CHEM., (1997), vol. 272, pages 10678 - 10684
    - ROSOK ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 22611 - 22618
    - VAN DIJK; VAN DE WINKEL, CURR. OPIN. PHARMACOL., (2001), vol. 5, pages 368 - 74
    - LONBERG, CURR. OPIN. IMMUNOL., (2008), vol. 20, pages 450 - 459
    - LONBERG, NAT. BIOTECH., (2005), vol. 23, pages 1117 - 1125
    - KOZBOR, J. IMMUNOL., (1984), vol. 133, page 3001
    - BRODEUR ET AL., Monoclonal Antibody Production Techniques and Applications, MARCEL DEKKER, INC., (1987), pages 51 - 63
    - BOERNER ET AL., J. IMMUNOL., (1991), vol. 147, page 86
    - LI ET AL., PROC. NATL. ACATL. SCI. USA, (2006), vol. 103, pages 3557 - 3562
    - NI, XIANDAI MIANYIXUE, (2006), vol. 26, no. 4, pages 265 - 268
    - VOLLMERS; BRANDLEIN, HISTOLOGY AND HISTOPATHOLOGY, (2005), vol. 20, no. 3, pages 927 - 937
    - VOLLMERS; BRANDLEIN, METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, (2005), vol. 27, no. 3, pages 185 - 91
    - Methods in Molecular Biology, HUMAN PRESS, (2001), vol. 178, pages 1 - 37
    - MCCAFFERTY ET AL., NATURE, vol. 348, pages 552 - 554
    - CLACKSON ET AL., NATURE, (1991), vol. 352, pages 624 - 628
    - MARKS ET AL., J. MOL. BIOL., (1992), vol. 222, pages 581 - 597
    - MARKS; BRADBURY, Methods in Molecular Biology, HUMAN PRESS, (2003), vol. 248, pages 161 - 175
    - SIDHU ET AL., J. MOL. BIOL., (2004), vol. 338, no. 2, pages 299 - 310
    - LEE ET AL., J. MOL. BIOL., (2004), vol. 340, no. 5, pages 1073 - 1093
    - FELLOUSE, PROC. NATL. ACAD. SCI. USA, (2004), vol. 101, no. 34, pages 12467 - 12472
    - LEE ET AL., J. IMMUNOL. METHODS, (2004), vol. 284, no. 1-2, pages 119 - 132
    - WINTER ET AL., ANN. REV. IMMUNOL., (1994), vol. 12, pages 433 - 455
    - GRIFFITHS ET AL., EMBO J, (1993), vol. 12, pages 725 - 734
    - HOOGENBOOM; WINTER, J. MOL. BIOL., (1992), vol. 227, pages 381 - 388
    - MILSTEIN; CUELLO, NATURE, (1983), vol. 305, page 537
    - TRAUNECKER ET AL., EMBO J., (1991), vol. 10, page 3655
    - BRENNAN ET AL., SCIENCE, (1985), vol. 229, page 81
    - KOSTELNY ET AL., J. IMMUNOL., (1992), vol. 148, no. 5, pages 1547 - 1553
    - GRUBER ET AL., J. IMMUNOL., (1994), vol. 152, page 5368
    - TUTT ET AL., J. IMMUNOL., (1991), vol. 147, page 60
    - CHOWDHURY, METHODS MOL. BIOL., (2008), vol. 207, pages 179 - 196
    - HOOGENBOOM ET AL., Methods in Molecular Biology, HUMAN PRESS, (2001), vol. 178, pages 1 - 37
    - CUNNINGHAM; WELLS, SCIENCE, (1989), vol. 244, pages 1081 - 1085
    - WRIGHT ET AL., TIBTECH, (1997), vol. 15, pages 26 - 32
    - OKAZAKI ET AL., J. MOL. BIOL., (2004), vol. 336, pages 1239 - 1249
    - YAMANE-OHNUKI ET AL., BIOTECH. BIOENG., (2004), vol. 87, page 614
    - RIPKA ET AL., ARCH. BIOCHEM. BIOPHYS., (1986), vol. 249, pages 533 - 545
    - KANDA, Y. ET AL., BIOTECHNOL. BIOENG., (2006), vol. 94, no. 4, pages 680 - 688
    - RAVETCH; KINET, ANNU. REV. IMMUNOL., (1991), vol. 9, pages 457 - 492
    - HELLSTROM, I. ET AL., PROC. NAT'L ACAD. SCI. USA, (1986), vol. 83, pages 7059 - 7063
    - HELLSTROM, I ET AL., PROC. NAT'L ACAD. SCI. USA, (1985), vol. 82, pages 1499 - 1502
    - BRUGGEMANN, M. ET AL., J. EXP. MED., (1987), vol. 166, pages 1351 - 1361
    - CLYNES ET AL., PROC. NAT'L ACAD. SCI. USA, (1998), vol. 95, pages 652 - 656
    - GAZZANO-SANTORO ET AL., J. IMMUNOL. METHODS, (1996), vol. 202, page 163
    - CRAGG, M.S. ET AL., BLOOD, (2003), vol. 101, pages 1045 - 1052
    - CRAGG, M.S.; M.J. GLENNIE, BLOOD, (2004), vol. 103, pages 2738 - 2743
    - PETKOVA, S.B. ET AL., INT'L. IMMUNOL., (2006), vol. 18, no. 12, pages 1759 - 1769
    - SHIELDS ET AL., J. BIOL. CHEM., (2001), vol. 9, no. 2, pages 6591 - 6604
    - IDUSOGIE ET AL., J. IMMUNOL., (2000), vol. 164, pages 4178 - 4184
    - GUYER ET AL., J. IMMUNOL., (1976), vol. 117, page 587
    - KIM ET AL., J. IMMUNOL., (1994), vol. 24, page 249
    - DUNCAN; WINTER, NATURE, (1988), vol. 322, pages 738 - 40
    - KAM ET AL., PROC. NATL. ACAD. SCI. USA, (2005), vol. 102, pages 11600 - 11605
    - CHARLTON, Methods in Molecular Biology, HUMANA PRESS, (2003), vol. 248, pages 245 - 254
    - GERNGROSS, NAT. BIOTECH., (2004), vol. 22, pages 1409 - 1414
    - LI ET AL., NAT. BIOTECH., (2006), vol. 24, pages 210 - 215
    - GRAHAM ET AL., J. GEN VIROL., (1977), vol. 36, page 59
    - MATHER, BIOL. REPROD., (1980), vol. 23, pages 243 - 251
    - MATHER ET AL., ANNALS N.Y. ACAD. SCI., (1982), vol. 383, pages 44 - 68
    - URLAUB ET AL., PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, page 4216
    - YAZAKI; WU, Methods in Molecular Biology, HUMANA PRESS, (2003), vol. 248, pages 255 - 268
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.